Biologics

MDPI AG

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Biologics is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
MDPI AG
ISSN
2673-8449
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
1,000 CHF
Articles in DOAJ
147
Declared review time
6 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2021-10-22
Indexing
DOAJ
APC
1,000 CHF
Declared review time (DOAJ)
6 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

147

Most recent article

4 months ago

Average review time (journal-declared via DOAJ)

6weeks

Works in OpenAlex

150

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

19

i10-index

34

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2023-04-12
Added to DOAJ
2021-10-22
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Open references deposited at Crossref
99%
ORCID iDs in current deposits
93%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918368081306676
Classification2

Subjects (DOAJ)

Science: Biology (General)

LCC codes

QH301-705.5

Subject areas

  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
  • Biosimilars and Bioanalytical Methods
  • Monoclonal and Polyclonal Antibodies Research
  • COVID-19 Clinical Research Studies
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
Show all subjects (75)
  • Probiotics and Fermented Foods
  • Biosimilars and Bioanalytical Methods
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • Biosimilars and Bioanalytical Methods
  • Pharmaceutical Economics and Policy
  • Psoriasis: Treatment and Pathogenesis
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • vaccines and immunoinformatics approaches
  • Medicinal Plant Research
  • Inflammatory Bowel Disease
  • Asthma and respiratory diseases
  • Mesenchymal stem cell research
  • Rheumatoid Arthritis Research and Therapies
  • Extracellular vesicles in disease
  • Phytochemicals and Antioxidant Activities
  • Immunotherapy and Immune Responses
  • Viral Infectious Diseases and Gene Expression in Insects
  • Glycosylation and Glycoproteins Research
  • Probiotics and Fermented Foods
  • Antimicrobial Peptides and Activities
  • Phytochemicals and Antioxidant Activities
  • Dermatology and Skin Diseases
  • Probiotics and Fermented Foods
  • Viral Infectious Diseases and Gene Expression in Insects
  • Glycosylation and Glycoproteins Research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Chemical Synthesis and Analysis
  • Computational Drug Discovery Methods
  • Psoriasis: Treatment and Pathogenesis
  • Immunotherapy and Immune Responses
  • Antimicrobial Peptides and Activities
  • Phytochemicals and Antioxidant Activities
  • Dermatology and Skin Diseases
  • Dermatologic Treatments and Research
  • Natural Antidiabetic Agents Studies
  • Transgenic Plants and Applications
  • Immunotherapy and Immune Responses
  • Aquaculture disease management and microbiota
  • Asthma and respiratory diseases
  • Neurogenesis and neuroplasticity mechanisms
  • Pharmaceutical studies and practices
  • Gut microbiota and health
  • Psoriasis: Treatment and Pathogenesis
  • Protein purification and stability
  • vaccines and immunoinformatics approaches
  • Transgenic Plants and Applications
  • Spondyloarthritis Studies and Treatments
  • Neurogenesis and neuroplasticity mechanisms
  • vaccines and immunoinformatics approaches
  • Pharmaceutical studies and practices
  • Long-Term Effects of COVID-19
  • Natural Antidiabetic Agents Studies
  • Asthma and respiratory diseases
  • Long-Term Effects of COVID-19
  • Natural Antidiabetic Agents Studies
  • Rheumatoid Arthritis Research and Therapies
  • Mosquito-borne diseases and control
  • Mosquito-borne diseases and control
  • Mesenchymal stem cell research
  • Osteoarthritis Treatment and Mechanisms
  • Gut microbiota and health
  • Inflammatory Bowel Disease
  • Gut microbiota and health
  • Osteoarthritis Treatment and Mechanisms
  • Inflammatory Bowel Disease

Keywords (DOAJ)

  • vaccines
  • hormones
  • cytokines and allied mediators
  • diagnostics
  • gene therapies
  • cytology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: